{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T22:12:23Z","timestamp":1648851143894},"reference-count":27,"publisher":"Japan Endocrine Society","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2015]]},"DOI":"10.1507\/endocrj.ej14-0616","type":"journal-article","created":{"date-parts":[[2015,6,12]],"date-time":"2015-06-12T22:24:52Z","timestamp":1434147892000},"page":"749-756","source":"Crossref","is-referenced-by-count":0,"title":["Possible predictors for QOL improvement following GH replacement therapy in adult GHD"],"prefix":"10.1507","volume":"62","author":[{"given":"Akira","family":"Shimatsu","sequence":"first","affiliation":[{"name":"Clinical Research Institute, National Hospital Organization Kyoto Medical Center, Kyoto, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriyuki","family":"Iwamoto","sequence":"additional","affiliation":[{"name":"Medical Science, Eli Lilly Japan K.K., Kobe, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiaki","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Tanaka Growth Clinic, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Teramoto","sequence":"additional","affiliation":[{"name":"Tokyo Rosai Hospital, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanori","family":"Taketsuna","sequence":"additional","affiliation":[{"name":"Statistical Science, Eli Lilly Japan K.K., Kobe, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuichiro","family":"Ihara","sequence":"additional","affiliation":[{"name":"Medical Science, Eli Lilly Japan K.K., Kobe, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jumpei","family":"Funai","sequence":"additional","affiliation":[{"name":"Science Communications, Eli Lilly Japan K.K., Kobe, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minoru","family":"Irie","sequence":"additional","affiliation":[{"name":"Professor Emeritus, Toho University, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuo","family":"Chihara","sequence":"additional","affiliation":[{"name":"Hyogo Prefectural Kakogawa Medical Center, Kakogawa, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"386","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Kargi AY, Merriam GR (2013) Diagnosis and treatment of growth hormone deficiency in adults. <i>Nat Rev Endocrinol<\/i> 9:335-345.","DOI":"10.1038\/nrendo.2013.77"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Carroll PV, Christ ER, Bengtsson BA, Carlsson L, Christiansen JS, et al. (1998) Growth hormone deficiency in adulthood and the effects of growth hormone replacement: A review. Growth Hormone Research Society Scientific Committee. <i>J Clin Endocrinol Metab<\/i> 83:382-395.","DOI":"10.1210\/jcem.83.2.4594"},{"key":"3","unstructured":"3. Attanasio AF, Lamberts SW, Matranga AM, Birkett MA, Bates PC, et al. (1997) Adult growth hormone (GH)-deficient patients demonstrate heterogeneity between childhood onset and adult onset before and during human GH treatment. Adult Growth Hormone Deficiency Study Group. <i>J Clin Endocrinol Metab<\/i> 82:82-88."},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Urushihara H, Fukuhara S, Tai S, Morita S, Chihara K (2007) Heterogeneity in responsiveness of perceived quality of life to body composition changes between adult- and childhood-onset Japanese hypopituitary adults with GH deficiency during GH replacement. <i>Eur J Endocrinol<\/i> 156:637-645.","DOI":"10.1530\/EJE-07-0016"},{"key":"5","unstructured":"5. National Institute for Health and Care Excellence. Human growth hormone (somatropin) in adults with growth hormone deficiency. 2003. Available at: http:\/\/www.nice.org.uk\/guidance\/TA64\/chapter\/1-guidance. Accessed 18 July 2014."},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Koltowska-Haggstrom M, Mattsson AF, Shalet SM (2009) Assessment of quality of life in adult patients with GH deficiency: KIMS contribution to clinical practice and pharmacoeconomic evaluations. <i>Eur J Endocrinol<\/i> 161 Suppl 1:S51-64.","DOI":"10.1530\/EJE-09-0266"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Cook DM, Yuen KC, Biller BM, Kemp SF, Vance ML (2009) American Association of Clinical Endocrinologists medical guidelines for clinical practice for growth hormone use in growth hormone-deficient adults and transition patients - 2009 update. <i>Endocr Pract<\/i> 15 Suppl 2:1-29.","DOI":"10.4158\/EP.15.S2.1"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Molitch ME, Clemmons DR, Malozowski S, Merriam GR, Vance ML, et al. (2011) Evaluation and treatment of adult growth hormone deficiency: An Endocrine Society clinical practice guideline. <i>J Clin Endocrinol Metab<\/i> 96:1587-1609.","DOI":"10.1210\/jc.2011-0179"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Hazem A, Elamin MB, Bancos I, Malaga G, Prutsky G, et al. (2012) Body composition and quality of life in adults treated with GH therapy: a systematic review and meta-analysis. <i>Eur J Endocrinol<\/i> 166:13-20.","DOI":"10.1530\/EJE-11-0558"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Gibney J, Wallace JD, Spinks T, Schnorr L, Ranicar A, et al. (1999) The effects of 10 years of recombinant human growth hormone (GH) in adult GH-deficient patients. <i>J Clin Endocrinol Metab<\/i> 84:2596-2602.","DOI":"10.1210\/jcem.84.8.5916"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Gilchrist FJ, Murray RD, Shalet SM (2002) The effect of long-term untreated growth hormone deficiency (GHD) and 9 years of GH replacement on the quality of life (QoL) of GH-deficient adults. <i>Clin Endocrinol (Oxf)<\/i> 57:363-370.","DOI":"10.1046\/j.1365-2265.2002.01608.x"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Rosilio M, Blum WF, Edwards DJ, Shavrikova EP, Valle D, et al. (2004) Long-term improvement of quality of life during growth hormone (GH) replacement therapy in adults with GH deficiency, as measured by questions on life satisfaction-hypopituitarism (QLS-H). <i>J Clin Endocrinol Metab<\/i> 89:1684-1693.","DOI":"10.1210\/jc.2003-030134"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Koltowska-Haggstrom M, Mattsson AF, Monson JP, Kind P, Badia X, et al. (2006) Does long-term GH replacement therapy in hypopituitary adults with GH deficiency normalise quality of life? <i>Eur J Endocrinol<\/i> 155:109-119.","DOI":"10.1530\/eje.1.02176"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Spielhagen C, Schwahn C, Moller K, Friedrich N, Kohlmann T, et al. (2011) The benefit of long-term growth hormone (GH) replacement therapy in hypopituitary adults with GH deficiency: results of the German KIMS database. <i>Growth Horm IGF Res<\/i> 21:1-10.","DOI":"10.1016\/j.ghir.2010.10.005"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Shimatsu A, Tai S, Imori M, Ihara K, Taketsuna M, et al. (2013) Efficacy and safety of growth hormone replacement therapy in Japanese adults with growth hormone deficiency: a post-marketing observational study. <i>Endocr J<\/i> 60:1131-1144.","DOI":"10.1507\/endocrj.EJ13-0083"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Wiren L, Bengtsson BA, Johannsson G (1998) Beneficial effects of long-term GH replacement therapy on quality of life in adults with GH deficiency. <i>Clin Endocrinol (Oxf)<\/i> 48:613-620.","DOI":"10.1046\/j.1365-2265.1998.00462.x"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Holmes SJ, Shalet SM (1995) Factors influencing the desire for long-term growth hormone replacement in adults. <i>Clin Endocrinol (Oxf)<\/i> 43:151-157.","DOI":"10.1111\/j.1365-2265.1995.tb01909.x"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Shimatsu A, Tai S, Tanaka T, Fujieda K, Teramoto A, et al. (2011) Clinical characteristics of Japanese adults with growth hormone deficiency: A HypoCCS database study. <i>Endocr J<\/i> 58:325-333.","DOI":"10.1507\/endocrj.K10E-363"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Fukuhara S, Bito S, Green J, Hsiao A, Kurokawa K (1998) Translation, adaptation, and validation of the SF-36 Health Survey for use in Japan. <i>J Clin Epidemiol<\/i> 51:1037-1044.","DOI":"10.1016\/S0895-4356(98)00095-X"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Suzukamo Y, Fukuhara S, Green J, Kosinski M, Gandek B, et al. (2011) Validation testing of a three-component model of Short Form-36 scores. <i>J Clin Epidemiol<\/i> 64:301-308.","DOI":"10.1016\/j.jclinepi.2010.04.017"},{"key":"21","unstructured":"21. Shimatsu A, Chihara K, Hizuka N, Teramoto A, Tanaka T, et al. (2007) Reference intervals of serum insulin-like growth factor-I in adult Japanese population: calculated with LMS methods. <i>Horumon to Rinsho<\/i> 55:393-399 (In Japanese)."},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Adamson U, Efendic S (1979) Insulin-like and diabetogenic effects of growth hormone in healthy subjects, diabetics, and low insulin responders. <i>J Clin Endocrinol Metab<\/i> 49:456-461.","DOI":"10.1210\/jcem-49-3-456"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Yuen K, Ong K, Husbands S, Chatelain P, Fryklund L, et al. (2002) The effects of short-term administration of two low doses versus the standard GH replacement dose on insulin sensitivity and fasting glucose levels in young healthy adults. <i>J Clin Endocrinol Metab<\/i> 87:1989-1995.","DOI":"10.1210\/jcem.87.5.8460"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Yuen KC, Frystyk J, White DK, Twickler TB, Koppeschaar HP, et al. (2005) Improvement in insulin sensitivity without concomitant changes in body composition and cardiovascular risk markers following fixed administration of a very low growth hormone (GH) dose in adults with severe GH deficiency. <i>Clin Endocrinol (Oxf)<\/i> 63:428-436.","DOI":"10.1111\/j.1365-2265.2005.02359.x"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Yuen KC, Roberts CT Jr, Frystyk J, Rooney WD, Pollaro JR, et al. (2014) Short-term, low-dose GH therapy improves insulin sensitivity without modifying cortisol metabolism and ectopic fat accumulation in adults with GH deficiency. <i>J Clin Endocrinol Metab<\/i> 99:E1862-1869.","DOI":"10.1210\/jc.2014-1532"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Svensson J, Finer N, Bouloux P, Bevan J, Jonsson B, et al. (2007) Growth hormone (GH) replacement therapy in GH deficient adults: predictors of one-year metabolic and clinical response. <i>Growth Horm IGF Res<\/i> 17:67-76.","DOI":"10.1016\/j.ghir.2006.11.002"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Murray RD, Skillicorn CJ, Howell SJ, Lissett CA, Rahim A, et al. (1999) Influences on quality of life in GH deficient adults and their effect on response to treatment. <i>Clin Endocrinol (Oxf)<\/i> 51:565-573.","DOI":"10.1046\/j.1365-2265.1999.00838.x"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/62\/8\/62_EJ14-0616\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,23]],"date-time":"2017-06-23T13:36:25Z","timestamp":1498224985000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/62\/8\/62_EJ14-0616\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":27,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.ej14-0616","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015]]}}}